As of 2026-03-26, the EV/EBITDA ratio of Globus Medical Inc (GMED) is 13.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GMED's latest enterprise value is 11,288.72 mil USD. GMED's TTM EBITDA according to its financial statements is 817.97 mil USD. Dividing these 2 quantities gives us the above GMED EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 14.4x | 13.4x |
| Forward P/E multiples | 14.2x - 17.3x | 14.4x |
| Fair Price | 72.71 - 106.55 | 86.88 |
| Upside | -16.8% - 22.0% | -0.5% |
| Date | EV/EBITDA |
| 2026-03-25 | 13.80 |
| 2026-03-24 | 13.62 |
| 2026-03-23 | 13.78 |
| 2026-03-20 | 13.62 |
| 2026-03-19 | 13.63 |
| 2026-03-18 | 13.67 |
| 2026-03-17 | 13.93 |
| 2026-03-16 | 13.54 |
| 2026-03-13 | 13.37 |
| 2026-03-12 | 13.33 |
| 2026-03-11 | 13.77 |
| 2026-03-10 | 13.69 |
| 2026-03-09 | 13.88 |
| 2026-03-06 | 13.76 |
| 2026-03-05 | 14.12 |
| 2026-03-04 | 14.32 |
| 2026-03-03 | 14.52 |
| 2026-03-02 | 14.87 |
| 2026-02-27 | 15.14 |
| 2026-02-26 | 15.35 |
| 2026-02-25 | 15.27 |
| 2026-02-24 | 14.55 |
| 2026-02-23 | 14.80 |
| 2026-02-20 | 14.34 |
| 2026-02-19 | 14.39 |
| 2026-02-18 | 14.26 |
| 2026-02-17 | 14.07 |
| 2026-02-13 | 13.92 |
| 2026-02-12 | 13.78 |
| 2026-02-11 | 13.95 |
| 2026-02-10 | 14.03 |
| 2026-02-09 | 13.84 |
| 2026-02-06 | 13.88 |
| 2026-02-05 | 13.83 |
| 2026-02-04 | 13.75 |
| 2026-02-03 | 13.82 |
| 2026-02-02 | 14.19 |
| 2026-01-30 | 14.35 |
| 2026-01-29 | 14.28 |
| 2026-01-28 | 14.54 |
| 2026-01-27 | 14.56 |
| 2026-01-26 | 14.73 |
| 2026-01-23 | 14.66 |
| 2026-01-22 | 15.01 |
| 2026-01-21 | 14.93 |
| 2026-01-20 | 14.73 |
| 2026-01-16 | 14.81 |
| 2026-01-15 | 14.88 |
| 2026-01-14 | 14.65 |
| 2026-01-13 | 14.27 |